Search results
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 5 days agoGSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure,...
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the...
Independent Advisor Alliance Has $740,000 Position in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 5 days agoIndependent Advisor Alliance decreased its position in GSK plc (NYSE:GSK – Free Report) by 8.9% in the 4th quarter, according to the company in its most ...
GSK faces whistleblower lawsuit over Zantac cancer risk | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 6 days agoGSK has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding...
Q3 2024 EPS Estimates for GSK plc Boosted by Zacks Research (NYSE:GSK)
ETF DAILY NEWS· 2 days agoGSK plc (NYSE:GSK – Free Report) – Analysts at Zacks Research increased their Q3 2024 earnings estimates for shares of GSK in a note ...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 2 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
GSK’s asthma drug shows promise in reducing severe attacks
WHTC 1450 Holland· 5 days ago(Reuters) - GSK's asthma drug met its primary goal of reducing asthma attacks over a 52-week period...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Market Watch· 5 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 5 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 4 days agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...